Szczepaniak L S, Babcock E E, Schick F, Dobbins R L, Garg A, Burns D K, McGarry J D, Stein D T
Center for Diabetes Research, University of Texas Southwestern Medical Center, Dallas, Texas 75235, USA.
Am J Physiol. 1999 May;276(5):E977-89. doi: 10.1152/ajpendo.1999.276.5.E977.
We validate the use of 1H magnetic resonance spectroscopy (MRS) to quantitatively differentiate between adipocyte and intracellular triglyceride (TG) stores by monitoring the TG methylene proton signals at 1.6 and 1.4 ppm, respectively. In two animal models of intracellular TG accumulation, intrahepatic and intramyocellular TG accumulation was confirmed histologically. Consistent with the histological changes, the methylene signal intensity at 1.4 ppm increased in both liver and muscle, whereas the signal at 1.6 ppm was unchanged. In response to induced fat accumulation, the TG concentration in liver derived from 1H MRS increased from 0 to 44.9 +/- 13.2 micromol/g, and this was matched by increases measured biochemically (2.1 +/- 1.1 to 46.1 +/- 10.9 micromol/g). Supportive evidence that the methylene signal at 1.6 ppm in muscle is derived from investing interfascial adipose tissue was the finding that, in four subjects with generalized lipodystrophy, a disease characterized by absence of interfacial fat, no signal was detected at 1.6 ppm; however, a strong signal was seen at 1.4 ppm. An identical methylene chemical shift at 1.4 ppm was obtained in human subjects with fatty liver where the fat is located exclusively within hepatocytes. In experimental animals, there was a close correlation between hepatic TG content measured in vivo by 1H MRS and chemically by liver biopsy [R = 0.934; P <.0001; slope 0.98, confidence interval (CI) 0.70-1.17; y-intercept 0.26, CI -0.28 to 0. 70]. When applied to human calf muscle, the coefficient of variation of the technique in measuring intramyocellular TG content was 11.8% in nonobese subjects and 7.9% in obese subjects and of extramyocellular (adipocyte) fat was 22.6 and 52.5%, respectively. This study demonstrates for the first time that noninvasive in vivo 1H MRS measurement of intracellular TG, including that within myocytes, is feasible at 1.5-T field strengths and is comparable in accuracy to biochemical measurement. In addition, in mixed tissue such as muscle, the method is clearly advantageous in differentiating between TG from contaminating adipose tissue compared with intramyocellular lipids.
我们通过分别监测1.6 ppm和1.4 ppm处的甘油三酯(TG)亚甲基质子信号,验证了利用1H磁共振波谱(MRS)对脂肪细胞和细胞内TG储存进行定量区分的方法。在两种细胞内TG蓄积的动物模型中,通过组织学方法证实了肝内和肌细胞内TG的蓄积。与组织学变化一致,肝脏和肌肉中1.4 ppm处的亚甲基信号强度均增加,而1.6 ppm处的信号未发生变化。在诱导脂肪蓄积后,通过1H MRS测得的肝脏TG浓度从0增加至44.9±13.2 μmol/g,且这与生化测定值的增加相匹配(从2.1±1.1 μmol/g增加至46.1±10.9 μmol/g)。支持肌肉中1.6 ppm处亚甲基信号源自包裹性筋膜间脂肪组织的证据是,在4例全身性脂肪营养不良患者(一种以缺乏界面脂肪为特征的疾病)中,未检测到1.6 ppm处的信号;然而,在1.4 ppm处可见强信号。在脂肪仅位于肝细胞内的脂肪肝患者中,也获得了1.4 ppm处相同的亚甲基化学位移。在实验动物中,通过1H MRS在体内测得的肝脏TG含量与肝脏活检化学测定值之间存在密切相关性[R = 0.934;P <.0001;斜率0.98,置信区间(CI)0.70 - 1.17;截距0.26,CI -0.28至0.70]。当应用于人体小腿肌肉时,该技术在测量非肥胖受试者肌细胞内TG含量时的变异系数为11.8%,在肥胖受试者中为7.9%,而测量细胞外(脂肪细胞)脂肪时的变异系数分别为22.6%和52.5%。本研究首次证明,在1.5-T场强下,通过非侵入性体内1H MRS测量包括肌细胞内TG在内细胞内TG是可行的,且在准确性上与生化测量相当。此外,在肌肉等混合组织中,与肌细胞内脂质相比,该方法在区分来自污染脂肪组织的TG方面具有明显优势。